Melania ticket sales suggest weak box office opening — and some theaters are cancelling screenings

Amazon MGM’s Melania documentary is tracking for a weak theatrical launch after $40 million was paid for the film and roughly $35 million was spent on marketing; pre-sales are close to $1 million and the film is projected to open around $5 million. Opening-day ticket counts are muted nationwide with some screenings canceled and international runs pulled for political reasons, while demand is concentrated in conservative markets; the film will later stream on Prime Video. Crew fallout around director Brett Ratner and the likely theatrical underperformance suggest limited near-term revenue upside and potential write-down risk for the studio’s investment.

Analysis

Market structure: The film’s weak theatrical start (≈$1M pre-sales vs. $75M sunk buy+marketing) is an idiosyncratic content loss that benefits Prime’s streaming bundle if viewers migrate; exhibitors with reliance on event/documentary traffic see localized downside (Vero Beach/Independence outliers) while national chains’ revenue impact is likely <1% per quarter. Amazon (AMZN) faces reputational and marginal margin pressure in MGM/content lines but the direct cash loss is immaterial relative to Amazon’s ~$1–2T market cap; the real question is signal risk to future content bids and amortization policy.

Risk assessment: Tail risks include a larger-than-expected impairment or change in amortization policy that forces a multi-hundred-million write-down if more titles underperform, regulatory scrutiny over political content, or a PR cascade affecting Prime subs. Immediate (days) risks: negative headlines and options vol spikes; short-term (weeks–months): streaming performance metrics and subscriber churn; long-term (quarters–years): changes to Amazon’s content strategy and M&A cadence. Hidden dependency: political polarization concentrates demand geographically, so box office is a poor proxy for streaming success.

Trade implications: Favor idiosyncratic hedges over directional bets — size exposure to AMZN core business (AWS) but protect media risk. Avoid adding exposure to theatrical exhibitors (AMC, CNK) who earn little from niche doc flops and may see softer specialty bookings; consider small option hedges around AMZN earnings and Prime Video release windows. Cross-asset: expect a modest uptick in AMZN implied volatility (IV) 30–60 days; bonds/FX/commodities unaffected.

Contrarian angle: The market is likely overfitting headlines to Amazon’s fundamentals — $75M is <0.1% of annual operating cash flow for AMZN; a controlled reaction creates a short-duration arbitrage: buy the dip in AMZN equity with disciplined, time-limited protection while screening for any follow-on content write-downs. Historical parallels: studio purchase flops typically cause short-lived equity dips but rarely change enterprise trajectories unless part of a pattern.

Key Decisions for Investors

• Establish a 1–2% portfolio long in AMZN (buy equity) over a 3–9 month horizon to play AWS/retail fundamentals; simultaneously purchase a 60-day ATM put sized to 0.25% of portfolio to cap downside or implement a 60/50 put spread if put premium >2% of position cost.
• Reduce or avoid incremental exposure to theatrical exhibitors: trim 1–3% gross exposure to AMC Entertainment (AMC) and Cinemark (CNK) for the next 3 months; these names have asymmetric downside from weaker specialty content and low pricing power.
• If AMZN IV rises >15% vs its 30-day average before next earnings, convert hedges into 90-day put spreads (buy ATM, sell 10–15% OTM) to lock protection at reduced net premium — exit hedges if Prime Video viewership for Melania >10M streams within 30 days.
• Monitor catalysts over next 30–90 days: (a) Prime Video release metrics and top-10 chart placement, (b) AMZN disclosure of any additional MGM impairments or policy changes, and (c) AMZN quarterly guidance; if any two occur indicating wider content write-down risk, reduce AMZN equity exposure by 50% within 5 trading days.